These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6805023)

  • 1. Lithium in combination with haloperidol or thyrotropin-releasing hormone induces jumping in mice.
    Ushijima I; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1982; 76(2):136-8. PubMed ID: 6805023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Psychopharmacology (Berl); 1982; 76(1):1-4. PubMed ID: 6281836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal mechanisms involved in drug-induced jumping behavior in mice.
    Ushijima I; Mizuki Y; Yamada M; Glavin GB
    Eur J Pharmacol; 1985 Jun; 112(2):225-9. PubMed ID: 2992995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.
    Ushijima I; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1984; 82(4):301-5. PubMed ID: 6427818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High doses of clonidine elicit jumping behavior in the mouse.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):367-77. PubMed ID: 6505377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and long-term treatments with thyrotropin-releasing hormone on locomotor activity and jumping behavior in mice.
    Ushijima I; Mizuki Y; Hara T; Watanabe K; Hirano H; Yamada M; Glavin GB
    Pharmacol Biochem Behav; 1986 May; 24(5):1423-8. PubMed ID: 3088609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
    Dunstan R; Jackson DM
    J Neural Transm; 1977; 40(3):181-9. PubMed ID: 874470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of lithium on presynaptic sites of catecholaminergic neurons in the mouse.
    Ushijima I; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):58-67. PubMed ID: 3094470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of dopamine receptor blockade on the TSH response to TRH in borderline personality disorder.
    Garbutt JC; Loosen PT; Glenn M
    Psychiatry Res; 1987 Aug; 21(4):307-11. PubMed ID: 3114780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Power spectral analysis of tremor induced by TRH and oxotremorine in mice].
    Koja T; Nomoto M; Shimizu T; Izumi K; Fukuda T
    Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):159-65. PubMed ID: 3095204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative maturation of the regulation of prolactin and thyrotropin by serotonin and thyrotropin-releasing hormone in male and female rats.
    Becú D; Libertun C
    Endocrinology; 1982 Jun; 110(6):1879-84. PubMed ID: 6804214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
    Matsui K; Ando K
    Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
    J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues.
    Heal DJ; Stoodley N; Elliott JM; Marsden CA; Bennett GW; Youdim MB
    Neuropharmacology; 1987 Apr; 26(4):313-22. PubMed ID: 2884590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
    Verimer T; Goodale DB; Long JP; Flynn JR
    J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
    [No Abstract]   [Full Text] [Related]  

  • 17. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new analogue of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents.
    Yamamoto M; Shimizu M
    Neuropharmacology; 1989 Aug; 28(8):863-6. PubMed ID: 2506487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral studies of shaking behavior induced by thyrotropin-releasing hormone and morphine withdrawal in rats.
    Yamada K; Matsuki J; Ushijima I; Inoue T; Furukawa T
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):24-33. PubMed ID: 6307193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice.
    Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.